Revolutionizing Drug Discovery with AI: Accelerating Medicine Development through Innovative Biologics| Sean McClain, CEO, Absci Corp. 00:10:00
This episode delves into the revolutionary potential of AI in drug discovery, highlighting Absci's innovative approach to creating more effective medicines faster and at a lower cost, with insights from its Founder/CEO and Chief AI Officer, Sean McClain and Joshua Meier. They discuss Absci's pooled approach to antibody production, emphasis on data, evaluation metrics for models, and their vision for the future of personalized medicine, aiming to positively impact human health.
